Announcements

Job offersmore »





Tweeting Growers

Top 5 - yesterday

  • No news has been published yesterday.

Top 5 - last week

Top 5 - last month

Exchange ratesmore »




Inocucor accelerates commercialization with $9.5 million investment

Inocucor uses a patented fermentation process to combine multi-strains of bacteria, yeasts and fungi into powerful biostimulants that naturally improve crop yields, shorten growing periods and create healthier, more resilient soils for farmers and greenhouse growers. A suite of microbial biocontrol products that target devastating diseases in potatoes, tomatoes and strawberries is also under development.

“We’ve come a long way in a few short years, with two products in use in the field, a signature line of biocontrol products under development and hundreds of field trials underway throughout the Americas,” said Inocucor’s President and CEO Donald R. Marvin. “Our business strategy and plan are guided by our vision for a Second Green Revolution for agriculture, one that uses earth-friendly farming products to improve crop yields, revitalize soils and improve water quality.”

Early next spring, Inocucor will occupy its new 30,000-square-foot U.S. headquarters and commercialization office currently under construction in Centennial, Colo. Its Montreal-based, R&D-focused Technical Center of Excellence is currently being enlarged from 10,000 to 20,000 square feet to house expanded product development and manufacturing operations. The company employs about 40 people in Montreal and the U.S., and anticipates adding another 25 to 30 high-level scientific and managerial professionals over the next year.

$9.5 million funding
Inocucor Corporation announced the $9.5 million USD ($12.1M CAD) second close of its Series B financing round. Funds raised to date in its Series B round now total $38.5 million USD ($50.9 million CAD).

The round was led by Pontifax AgTech, a growth capital investor in the global food and agriculture sector.

Other participants in the second Series B round include existing investors Cycle Capital Management (Montreal), Desjardins Innovatech (Montreal) and Cairn Investments (Denver). Inocucor’s first Series B equity financing of $29 million USD ($38.8 million CAD) in March 2017 was led by TPG ART with participation from existing investors.

Funds will enable Inocucor to accelerate its commercialization activities, through the increased production and marketing of its first- and second-generation biostimulant products, Synergro and Synergro Free. They will also advance development of a new suite of biocontrol products that combat economically devastating diseases in high-value crops such as strawberries, tomatoes and potatoes.

For more information
Inocucor


Publication date: 1/9/2018

 


 

Other news in this sector:

5/18/2018 CAN (QC): Lambert celebrates 90 years
5/18/2018 "Offering and unifying all our brands"
5/18/2018 Accelerated production plan for Pure Sunfarms
5/18/2018 Kenya: Mobile platform receives $100,000 grant to grow farmers’ reach
5/18/2018 Disease-resistant GMO tomatoes, strawberries and citrus in the pipeline
5/17/2018 CropNuts and AGI’s Yargus division enter soil testing services agreement
5/16/2018 Aeroponic greenhouse opens in Turin
5/16/2018 Auscitrus build insect-proof greenhouse for citrus Australia
5/16/2018 "Consumers are increasingly discovering the sweet pointed pepper"
5/16/2018 Fluence Bioengineering hires Director of Cultivation Support
5/16/2018 US tomato farm workers march against Wendy’s fast food chain
5/15/2018 Motorleaf’s $2.85M seed round accelerates AI in greenhouse operations
5/15/2018 "In Asian cultures, daikon is a staple"
5/15/2018 US: Canopy Growth to list on the NYSE
5/15/2018 Australia: Growcom introduces new CEO, David Thomson
5/14/2018 Biobest UK appoints Simon Jones as Phil Walker retires
5/14/2018 US: Horticultural Research Institute calls for research proposals
5/14/2018 Harvest House cooperative acquires Snijpunt
5/14/2018 Focus on the substances of the plant
5/14/2018 PHL, Israel to set up ‘modern’ farm in Clark